Article
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer
2024-04-20
Abstract excerpt
While colorectal cancer (CRC) patients with microsatellite instability (MSI) respond well to immunotherapy those with microsatellite stable (MSS) tumors rely on conventional chemotherapy, often with poor outcomes. Both types frequently carry mutations in KRAS or BRAF proto-oncogenes, rendering them more resistant to treatment. New therapeutic biomarkers and treatments remain a clinical need, especially for MSS t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3ebbe9b3-36d9-5263-9fef-ad072c06ad52
- DOI
- 10.1101/2024.04.17.589725
